▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #1764 by analyst upside · 2026-08-13
BTSG
BrightSpring Health Services, Inc.
Healthcare · Market Cap $12B · P/E 53.3x
ANALYST PRICE TARGET
+32.3%
implied upside to consensus target
Current Price $59.68
Consensus Target $78.94
Bull Target $90.0
Bear Target $70.0
Analysts Covering 17
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
14
Hold
0
Sell
0
52-Week Low $21.58
52-Week High $73.75
YTD Return +55.4%
FUNDAMENTALS
Market Cap $12B
P/E Ratio (TTM) 53.3x
Forward P/E 26.2x
EPS (TTM) $1.12
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $14.4B
Profit Margin 2.5%
52-WEEK RANGE
52-Week Low $21.58
52-Week High $73.75
Current Price $59.68
Bear Target $70.0
Bull Target $90.0
● Now $59.68 ● Target $78.94
TRADING DATA
Avg Volume 3.9M
YTD Return +55.4%
Analyst Count 17
Consensus Buy
Upside to Target +32.3%
Last Updated 2026-08-13

ANALYST SUMMARY

BrightSpring Health Services, Inc. (BTSG) is currently trading at $59.68 with a Wall Street consensus price target of $78.94, implying potential upside of 32.3% over the next 12 months. 17 analysts currently cover BTSG, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $90.0, while the most cautious has a target of $70.0.

BTSG operates in the Healthcare sector with a market capitalisation of $12B. The stock is up 55.4% year-to-date and is currently trading near the upper end of its 52-week range of $21.58 – $73.75.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RVTY +2.7%
Revvity, Inc.
$13B · P/E 56.7x · Hold
KRYS +15.0%
Krystal Biotech, Inc.
$10B · P/E 41.0x · Buy
ALGN +19.9%
Align Technology, Inc.
$12B · P/E 30.1x · Buy
HQY +12.4%
HealthEquity, Inc.
$9B · P/E 39.5x · Buy
ENSG +21.1%
The Ensign Group, Inc.
$11B · P/E 28.5x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for BTSG, with each firm's 90-day track record across all stocks we track. See full firm rankings →

TD Cowen - Reiterated
Buy → Buy 2026-06-18 Building track record
Goldman Sachs ● Initiated
Buy → Buy 2026-06-08 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-06-02 Building track record
Morgan Stanley - Reiterated
Overweight → Overweight 2026-05-06 Building track record
Mizuho - Reiterated
Outperform → Outperform 2026-05-05 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-04 Building track record
TD Cowen - Reiterated
Buy → Buy 2026-05-04 Building track record
Keybanc - Reiterated
Overweight → Overweight 2026-05-04 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
72
out of 100
Coverage depth
22/30
Consensus clarity
23/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →